CD38 and Miyoshi myopathy: Briefly, it binds with high affinity to a specific CD38 epitope on CD38-expressing MM cells and induces complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and antibody-dependent cellular phagocytosis (ADCP) against myeloma cells [3].